MZE-001

N/A

Report date: 2026/02/11 20:01:36
NME

Base Information

Drug NameMZE-001
Drug Alias NameMZE-001S-606001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycogen synthase 1 inhibitors
TargetsGlycogen synthase 1
Therapy Area/IndicationsGlycogen Storage Disease Type II
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesNetherlands +[10] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMaze Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSanofiShionogi & Co LtdMaze Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGlycogen Storage Disease Type II
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A